🇺🇸 FDA
Patent

US 7541429

Comparative ligand mapping from MHC positive cells

granted A61KA61K2039/605A61K2039/622

Quick answer

US patent 7541429 (Comparative ligand mapping from MHC positive cells) held by The Board of Regents of the University of Oklahoma expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/605, A61K2039/622, A61K39/39